While the condition can impact quality of life and mental health, seeking treatment and support can make a powerful ...

The U.S. Food and Drug Administration (FDA) announced the target action date of its review of the sNDA for VTAMA (tapinarof) cream, 1% has changed.

The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for tapinarof cream, 1% in the treatment of atopic dermatitis in adults and ...

The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...

The ADapt study assessed the efficacy and safety of EBGLYSS in individuals who had previously been treated with dupilumab.

Organon, which is seeking approval of Vtama as a treatment for atopic dermatitis, said the FDA set a new target action date of March 12 for a decision after requesting the final datasets and ...

Home remedies can complement prescribed treatments ... are key to controlling the condition in the long run. ALSO READ: Atopic dermatitis vs Contact dermatitis: Know the difference between these ...

Atopic dermatitis can have a significant impact on quality of life in adolescents, so new efficient treatments are needed to ...

ChatGPT recommendations regarding atopic dermatitis (AD) often differ from AAAAI/ACAAI practice parameter recommendations.

Among the various treatment strategies, the use of specialized emollients plays a crucial role in maintaining skin hydration and barrier function. Atopic dermatitis is a prevalent condition in ...

There isn’t a cure for atopic dermatitis, but there are ways to manage mild symptoms at home, experts said ... experts said. No treatment option is perfectly effective for everyone, Dr. Yu ...

The Phase III ECZTEND study reported that patients treated with Adbry demonstrated long term safety and efficacy for up to ...